Ireland· IE-PA-PA2059/062/001
SMOFlipid 200 mg/ml emulsion for infusion, glass bottle
A fettemulsionen product containing soybean oil + triglycerides, medium chain + refined olive oil + fish oil, rich in omega-3 acids, registered in Ireland by Fresenius Kabi Deutschland GmbH. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Fettemulsionen is registered in 11 of 19 countries.
Countries holding a registration under ATC B05BA02 (fettemulsionen), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Fettemulsionen · ATC B05BA02
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Soybean oil + Triglycerides, medium chain + Refined olive oil + Fish oil, rich in omega-3 acids
- Manufacturer
- Fresenius Kabi Deutschland GmbH
- Country
- Ireland (IE)
- ATC code
- B05BA02
- ATC class
- Fettemulsionen
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA2059/062/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B05BA02
Fettemulsionen, as other registers publish it.
- FinlandClinoleicBaxter Oy
- DenmarkClinoleicBaxter A/S
- NorwayClinoleicBaxter Medical AB
- CzechiaCLINOLEICBAXTER CZECH spol. s r.o., Praha
- CzechiaCLINOLEICBAXTER CZECH spol. s r.o., Praha
- CzechiaCLINOLEICBAXTER CZECH spol. s r.o., Praha
- CzechiaCLINOLEICBAXTER CZECH spol. s r.o., Praha
- CzechiaCLINOLEICBAXTER CZECH spol. s r.o., Praha
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/edd97126-2441-4f53-870a-1f7bb8c63c7a GET /v1/drugs/edd97126-2441-4f53-870a-1f7bb8c63c7a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Emulsion for infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"B05BA",
"B05BA02"
],
"strength": null,
"pa_number": "PA2059/062/001",
"substances": [
"Soybean oil",
"Triglycerides, medium chain",
"Refined olive oil",
"Fish oil, rich in omega-3 acids"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "27/10/2004",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about fettemulsionen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.